Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Executive or director change · Other events
  5. 8-K Event Material agreement
  6. 8-K Event Material agreement · Delisting notice · Executive or director change
  7. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  8. 8-K Event Executive or director change · Other events
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Agreement ended
  12. 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · Regulation FD disclosure · Other events
  13. 8-K Event Delisting notice
  14. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  15. 8-K Event Other events
  16. 8-K Event Shareholder vote results
  17. 8-K Event Executive or director change
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 4 of 12 · 221 filings